Acute Acquired Comitant Esotropia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acute Acquired Comitant Esotropia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT06966999

Efficacy of Botulinum Toxin Type A for Acute Acquired Comitant Esotropia: An Age-Stratified Two-Year Follow-Up Study

The goal of this clinical trial is to assess and compare the efficacy of two-year follow-up botulinum toxin type A （BTXA) in the treatment of acute acquired com…

China276 participantsStarted 2019-01-01

Treatment: Botulinum Toxin Type A Injection [Botox]